Project Grant HT94252510366
Award Date
9/1/25
Completion Date
8/31/28
Dollars Obligated
$526K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Tuscaloosa, AL 35401, USA
Similar Awards
This Project Grant award of $1,113,750.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), supports the University of Alabama at Birmingham (UAB) in developing "DUAL CD24/CD276 TARGETING THERAPIES FOR TRIPLE-NEGATIVE BREAST CANCER." The 3-year award, running from August 1, 2023 to July 31, 2026, will fund research to investigate medical solutions for the battlefield and transform health care for service members and the public...
The University of Alabama at Birmingham was awarded a $220,326 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on April 1, 2025, with a completion date of March 31, 2027, supports the development of novel, selective PARP protein degraders for prostate cancer treatment, utilizing PSMA uptake enhancement. This research aims to transform healthcare for military service members, veterans, and the broader...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $1,485,001.00 to the University of Alabama at Birmingham (UAB) to conduct research on "Overcoming Perturbations that Orchestrate Immune Exhaustion and Dysfunction in Breast Cancer." The research aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative medical solutions to address...
The University of Alabama at Birmingham (UAB) was awarded a $733,662 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 1, 2024, supports research to investigate the role of tumor glycans in immune suppression. This federally funded project aims to advance scientific understanding of how specific carbohydrate molecules on tumor cells can inhibit the body's immune response, with the goal of...
This $633,376 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Alabama at Birmingham (UAB) on September 1, 2023. The grant supports epigenome editing research to reactivate the FOXP3 gene in breast cancer tumors, with the goal of developing new treatments. The research project is scheduled for completion by August 31, 2026. UAB is a public research university known for its interdisciplinary...
The federal Project Grant award of $585,759.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded to Emory University on September 1, 2025, is intended to support research targeting GPNMB to improve the efficacy of CDK4/6 inhibitors in estrogen receptor-positive (ER+) breast cancer. The research will be conducted at Emory University in Atlanta, Georgia, and is expected to be completed by August 31, 2028. The...
This Project Grant award of $650,845, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research at the University of Alabama at Birmingham (UAB) focused on developing macrophage-centric prognostic biomarkers for checkpoint blockade immunotherapy in melanoma. The research aims to transform healthcare for military service members, veterans, and the broader public by investigating innovative medical...
This Project Grant award of $1,177,716.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), supports research at the University of Alabama at Birmingham (UAB) to investigate the "Metabolic Regulation of Metastatic Potential Through mRNA Translation." The award, which began on July 15, 2024 and will run through July 14, 2028, aims to advance scientific understanding of cancer metastasis through the study of metabolic processes and...
This federal Project Grant award of $1,317,584.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Alabama at Birmingham (UAB) aimed at developing macrophage-centric prognostic biomarkers for checkpoint blockade immunotherapy in melanoma. The 3-year project, which commenced on July 1, 2025, leverages UAB's extensive biomedical research capabilities and expertise in areas such as cancer,...
The University of Alabama will receive $749,987 under a three-year Project Grant award from the Defense Health Agency to investigate the role of environmental stressors on veteran neurocognitive aging. The grant, issued under the Military Medical Research and Development program (CFDA 12.420), will support research from May 2023 to April 2026. The Military Medical Research and Development program aims to transform military and public health through innovative medical research. This award will...